Wilmot Cancer Institute / Research Wilmot Research Wilmot is a leader in cancer research and here's why: Wilmot Cancer Institute scientists aided in two of the top five , as cited by the American Society of Clinical Oncology (ASCO): Contributions to the HPV cervical cancer vaccine, and pioneering work toward anti-nausea therapies to help patients tolerate chemotherapy. Wilmot is at the epicenter of cancer control research, as one of two U.S. hubs for the National Community Oncology Research Program (NCORP). Wilmot is a trailblazer in aging and cancer research, helping write the for managing older patients taking chemotherapy, and starting one of the nation's first geriatric oncology clinics. Wilmot is at the forefront of lymphoma research by often leading the nation in clinical trial accruals, holding top positions in key organizations including the SWOG lymphoma committee, and being among the first institutions to offer cellular (CAR T-cell) therapy backed by ongoing research. Research Programs Investigators work in three multidisciplinary, collaborative programs that study cancer biology, the tumor microenvironment, and toxicities and side effects of cancer and its treatment. Research Programs Research Faculty Wilmot has more than 125 dedicated scientists from 26 academic departments across the University of Rochester who are devoted to studying cancer. Research Faculty Shared Resources Shared Resources provide cost-effective access to state-of-the art technologies, expert guidance and training, and scientific consultation for Wilmot researchers. Shared Resources Clinical Trials Clinical trials are the backbone of cancer research, identifying better and safer treatments for patients. Clinical Trials Funding Opportunities Wilmot offers a variety of intramural funding mechanisms to support cancer researchers, as well as resources for extramural funding. Funding Opportunities Membership A community of scientists investigating how cancer occurs, and better ways to prevent, diagnosis, and treat cancer and its side effects. Membership